Luminex up 9% on emergency use nod for COVID-19 blood test

Luminex (LMNX +9.3%) is up 15% higher volume on the heels of U.S. emergency use authorization for its xMAP SARS-CoV-2 IgG antibody test.

In April, it received the emergency use nod for its test that detects the presence of the coronavirus.

https://seekingalpha.com/news/3592299-luminex-up-9-on-emergency-use-nod-for-covidminus-19-blood-test